Ember Therapeutics, Inc. - NY Inactive 10-Q2008 Q1 Quarterly report

Filed: 7 Nov 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: Additionally, allocate, allocated, allocating, allocation, analytical, applying, arising, Article, ASC, ASU, audit, award, balance, beginning, CA, choose, claim, Codification, compensation, conformity, consisting, CPA, cure, cured, curing, deliver, deliverable, delivered, Diego, element, eliminated, Embedded, employee, entity, essential, estimated, evidence, excluded, extent, facesignificantly, fall, function, functionality, grant, granted, guidance, Hedging, holder, impact, Incremental, individual, interim, measurement, necessarily, nominal, November, objective, October, option, payment, PLS, professional, rationale, recognition, recognized, recurring, regularly, rendered, residual, return, revenue, reverse, San, SC, scope, separate, separately, settlement, seventeen, sheet, software, standard, thereto, Topic, unaudited, undelivered, unit, United, withstand

Removed: affiliated, August, calendar, computation, computed, depressive, enactment, holding, merging, month, paragraph, preferred, realized, reduced, researching, restricted, volume, waived, weekly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Ember Therapeutics, Inc. - NY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)	The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:	November 7, 2012	By:	/S/Lisa Norman LISA NORMAN Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.